Intraartecular Platelet Rich Plasma for Sacroiliitis

A prospective randomized controlled study was conducted at the department of anesthesiology Mansoura University Hospital during the period from December 2017 to January 2019 on fifty ASA I‐III adult patients, of both sex after approval of IRB (Institutional Review Board) ID number MS17.10.03 & IRB date 12‐11‐2017. The patients were randomly allocated into two groups each of 25 patients according to computer‐generated random number codes that were placed in sealed envelopes, double blinded, with parallel‐group comparison. Steroid Group (S) (n. 25):‐ Patients were injected by 4 ml of sterile water containing the methylprednisolone Acetate (Depo‐Medrol) per‐kg calculated dose (0.5mg/kg up to a lean muscle body weight of 80kg in the painful sacroiliac joint). Platelet rich plasma Group (P) (n. 25):‐Patients received fixed volume of 4 ml platelet‐rich plasma in the inflamed painful sacroiliac joint.